Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides:: a comparative study

被引:196
|
作者
El-Andaloussi, Samir
Jarver, Peter [1 ]
Johansson, Henrik J.
Langel, Ulo
机构
[1] Stockholm Univ, Dept Neurochem, S-16091 Stockholm, Sweden
[2] Univ Tartu, Inst Technol, Lab Mol Biotechnol, EE-50090 Tartu, Estonia
关键词
cell-penetrating peptide; cytotoxicity; delivery vector; penetratin; transactivator of transcription (Tat); transport;
D O I
10.1042/BJ20070507
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of CPPs (cell-penetrating peptides) as delivery vectors for bioactive molecules has been an emerging field since 1994 when the first CPP, penetratin, was discovered. Since then, several CPPs, including the widely used Tat (transactivator of transcription) peptide, have been developed and utilized to translocate a wide range of compounds across the plasma membrane of cells both in vivo and in vitro. Although the field has emerged as a possible future candidate for drug delivery, little attention has been given to the potential toxic side effects that these peptides might exhibit in cargo delivery. Also, no comprehensive study has been performed to evaluate the relative efficacy of single CPPs to convey different cargos. Therefore we selected three of the major CPPs, penetratin, Tat and transportan 10, and evaluated their ability to deliver commonly used cargos, including fluoresceinyl moiety, double-stranded DNA and proteins (i.e. avidin and streptavidin), and studied their effect on membrane integrity and cell viability. Our results demonstrate the unfeasibility to use the translocation efficacy of fluorescein moiety as a gauge for CPP efficiency, since the delivery properties are dependent on the cargo used. Furthermore, and no less importantly, the toxicity of CPPs depends heavily on peptide concentration, cargo molecule and coupling strategy.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 50 条
  • [1] Cell-penetrating peptides: Application in vaccine delivery
    Brooks, Nicole A.
    Pouniotis, Dodie S.
    Tang, Choon-Kit
    Apostolopoulos, Vasso
    Pietersz, Geoffrey A.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2010, 1805 (01): : 25 - 34
  • [2] When cationic cell-penetrating peptides meet hydrocarbons to enhance in-cell cargo delivery
    Di Pisa, Margherita
    Chassaing, Gerard
    Swiecicki, Jean-Marie
    JOURNAL OF PEPTIDE SCIENCE, 2015, 21 (05) : 356 - 369
  • [3] Redesigning of Cell-Penetrating Peptides to Improve Their Efficacy as a Drug Delivery System
    Szabo, Ildiko
    Yousef, Mo'ath
    Soltesz, Dora
    Bato, Csaba
    Mezo, Gabor
    Banoczi, Zoltan
    PHARMACEUTICS, 2022, 14 (05)
  • [4] Is there a future for cell-penetrating peptides in oligonucleotide delivery?
    Lee, Soo Hyeon
    Castagner, Bastien
    Leroux, Jean-Christophe
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (01) : 5 - 11
  • [5] Cell-Penetrating Peptides as Delivery Enhancers for Vaccine
    Jiang, Yuhong
    Li, Man
    Zhang, Zhirong
    Gong, Tao
    Sun, Xun
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2014, 15 (03) : 256 - 266
  • [6] Cell-penetrating peptides for the delivery of nucleic acids
    Lehto, Taavi
    Kurrikoff, Kaido
    Langel, Ulo
    EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (07) : 823 - 836
  • [7] Cell-penetrating peptides for siRNA delivery to glioblastomas
    Srimanee, Artita
    Arvanitidou, Maria
    Kim, Kumjee
    Hallbrink, Mattias
    Langel, Ulo
    PEPTIDES, 2018, 104 : 62 - 69
  • [8] Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer
    Bolhassani, Azam
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2011, 1816 (02): : 232 - 246
  • [9] Cell-Penetrating Peptides: Efficient Vectors for Vaccine Delivery
    Yang, Jieru
    Luo, Yacheng
    Shibu, Mohini Anjna
    Toth, Istvan
    Skwarczynski, Mariusz
    CURRENT DRUG DELIVERY, 2019, 16 (05) : 430 - 443
  • [10] In Vivo Delivery of Morpholino Oligos by Cell-Penetrating Peptides
    Moulton, Hong M.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (16) : 2963 - 2969